| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/10/2012 | US8153673 Metalloproteinase inhibitors |
| 04/10/2012 | US8153652 Fab I inhibitors |
| 04/10/2012 | US8153625 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
| 04/10/2012 | US8153587 Orally administering parathyroid hormone and calcitonin |
| 04/10/2012 | US8153581 Process for producing an injectable medicament preparation |
| 04/10/2012 | US8153398 Polynucleotides encoding signal peptide-containing molecules |
| 04/10/2012 | US8153384 Marks as modifiers of the p53 pathway and methods of use |
| 04/10/2012 | US8153158 Tissue substitutes comprising stem cells and reduced ceria |
| 04/10/2012 | US8153113 Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue |
| 04/10/2012 | CA2662967C Medicinal composition |
| 04/10/2012 | CA2526540C Cyclicamino-phenyl sulfamate derivatives |
| 04/10/2012 | CA2491802C Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 04/10/2012 | CA2486308C Hepatitis c virus inhibitors |
| 04/10/2012 | CA2477857C Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 04/10/2012 | CA2446506C Methods for treating delirium using glucocorticoid receptor-specific antagonists |
| 04/10/2012 | CA2445408C Quinolone carboxylic acid compositions and related methods of treatment |
| 04/10/2012 | CA2378456C Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies |
| 04/05/2012 | WO2012043838A1 Inhibitor for hepatitis c virus infection |
| 04/05/2012 | WO2012043638A1 (aza)indolizine derivative and pharmaceutical use thereof |
| 04/05/2012 | WO2012043533A1 Antihuman ccr7 antibodies, hybridoma, nucleic acid, vector, cell, medicinal composition, and antibody-immobilized carrier |
| 04/05/2012 | WO2012043185A1 Composition for inhibiting il-8 expression |
| 04/05/2012 | WO2012042951A1 Atorbastatin-containing medicinal tablet |
| 04/05/2012 | WO2012042915A1 Sulfamoyl benzoic acid heterobicyclic derivatives as trpm8 antagonists |
| 04/05/2012 | WO2012042618A1 Composition for regenerating follicle which contains cd36-expressing connective tissue sheath cells |
| 04/05/2012 | US20120083496 Isoxazole compound for the treatment of cancer |
| 04/05/2012 | US20120083494 Novel triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors |
| 04/05/2012 | US20120083490 Cytochrome p450 oxidase inhibitors and uses thereof |
| 04/05/2012 | US20120083481 Formulations of deoxycholic acid and salts thereof |
| 04/05/2012 | US20120083476 Heteroaryl-substituted spirocyclic diamine urea modulators of fatty acid amide hydrolase |
| 04/05/2012 | US20120083473 Treatment of conditions by toll-like receptor modulators |
| 04/05/2012 | US20120083468 Method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis |
| 04/05/2012 | US20120082701 Polarized scorpion venom solution and a method for making polarized scorpion venom solution |
| 04/05/2012 | US20120082653 Methods of lysosomal storage disease therapy |
| 04/05/2012 | US20120082632 Topical drug delivery system with dual carriers |
| 04/05/2012 | CA2813203A1 Anti-human ccr7 antibody, hybridoma, nucleic acid, vector, cell, pharmaceutical composition, and antibody-immobilized carrier |
| 04/05/2012 | CA2811773A1 (aza)indolizine derivative and pharmaceutical use thereof |
| 04/04/2012 | EP2436762A1 Method for prediction of therapeutic effect of chemotherapy employing expression level of dihydropyrimidine dehydrogenase gene as measure |
| 04/04/2012 | EP2436676A1 Human adam-10 inhibitors |
| 04/04/2012 | EP2436675A1 Novel -phenoxybenzeneacetic acid derivative and pharmaceutical preparation comprising same |
| 04/04/2012 | EP2436672A1 Anti-shock agent comprising diaminotrifluoromethylpyridine derivative |
| 04/04/2012 | EP2436670A1 Preparation methods and uses of 1-(substituted aryl)-5-trifluoromethyl-2-(1h)-pyridone compounds and their salts |
| 04/04/2012 | EP2435470A1 Muteins of the pyrroline-5-carboxylate reductase 1 |
| 04/04/2012 | EP2251011B1 Solid preparation for oral administration |
| 04/04/2012 | EP1990343B1 Azaindoles |
| 04/04/2012 | EP1576960B1 Composition containing green and yellow vegetables and light-colored vegetables |
| 04/04/2012 | EP1557418B1 Quinoxaline derivatives |
| 04/04/2012 | EP1557414B1 Isoquinoline compounds and medicinal use thereof |
| 04/04/2012 | EP1397158B1 USE OF IgM ANTIBODIES AGAINST dsDNA IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS |
| 04/04/2012 | EP1316316B1 Preparations for oral administration |
| 04/04/2012 | EP1105403B1 3'-desoxypentopyranosyl nucleic acid and its production |
| 04/04/2012 | EP0783893B1 Inhibition of abnormal growth of synovial cells using il-6 antagonist as active ingredient |
| 04/04/2012 | CN202179781U 合并胆经、脾经两组织疾病的治疗装置 The combined treatment means gall bladder, spleen disease, the two organizations |
| 04/04/2012 | CN1630510B Atorvastatin calcium in a pharmaceutical form, composition thereof, and pharmaceutical formulation comprising atorvastatin calcium |
| 04/04/2012 | CN102405209A Diacylethylenediamine compound |
| 04/04/2012 | CN102399741A Culture solution and method for producing hemopoietic stem cell by reversely splitting somatic cell and application of culture liquid |
| 04/04/2012 | CN102399284A 狐狸生长激素释放激素cDNA及其应用 Fox ghrelin cDNA and Its Applications |
| 04/04/2012 | CN102399283A 水貂生长激素释放激素cDNA及其应用 Mink growth hormone releasing hormone cDNA and Its Applications |
| 04/04/2012 | CN102399220A 三并环类PI3K和mTOR双重抑制剂 Three and ring type PI3K and mTOR dual inhibitors |
| 04/04/2012 | CN102397400A 一种预防和治疗抗凝剂后遗症－毛细血管渗血的中草药组合物 Anticoagulants for preventing and treating sequelae - capillary oozing of herbal compositions |
| 04/04/2012 | CN102397393A Compound propolis composition for treating sudden death syndrome in poultry, and preparation method thereof |
| 04/04/2012 | CN102397317A Method for producing soybean Genistin and application of soybean Genistin in preparation of estrogenic drugs or female health food |
| 04/04/2012 | CN102397233A Fatigue-restraining soaking bath cream |
| 04/04/2012 | CN102178817B 一种治疗多发性脂肪瘤的中药组合物 A treatment for multiple lipoma herbal composition |
| 04/04/2012 | CN101501026B 含有烷基醚衍生物或其盐的蛋白激酶c活性促进剂 Containing alkyl ether derivative of protein kinase c active accelerator |
| 04/04/2012 | CN101157720B 作为丝氨酸蛋白酶抑制剂的模板固定肽模拟物 Fixed peptide mimetic as a template the serine protease inhibitor |
| 04/04/2012 | CN101117330B 异法戈明酒石酸盐及其应用方法 Iso Fage Ming tartrate and application method |
| 04/03/2012 | USRE43298 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 04/03/2012 | US8148525 2,4-pyrimidinediamine compounds and their uses |
| 04/03/2012 | US8148507 Nucleic acid encoding TNFx protein |
| 04/03/2012 | US8148493 Method for inhibiting “melanoma inhibitory activity” MIA |
| 04/03/2012 | US8148429 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 04/03/2012 | US8148371 Adenine compound and use thereof |
| 04/03/2012 | US8148125 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 04/03/2012 | US8147872 Pharmaceutical compositions of drugs and neutralized acidic polymers |
| 04/03/2012 | US8147845 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions |
| 04/03/2012 | CA2656916C Novel lactic acid bacteria |
| 04/03/2012 | CA2493812C Novel imidazole compounds, method for preparing same and use thereof as medicines |
| 04/03/2012 | CA2459309C Sustained release of microcrystalline peptide suspensions |
| 04/03/2012 | CA2435466C Use of il-18 inhibitors for the treatment and/or prevention of heart disease |
| 04/03/2012 | CA2432792C Methods for modulating tumor growth and metastasis |
| 04/03/2012 | CA2423744C Hydroxamic acid compounds comprising a sulfonamide linkage as hdac inhibitors |
| 03/29/2012 | WO2012040465A2 Multipotent stem cells and uses thereof |
| 03/29/2012 | WO2012039460A1 Substituted amide compound |
| 03/29/2012 | WO2012039447A1 Crystals of substituted cycloalkene derivatives |
| 03/29/2012 | WO2012039414A1 Substituted polycyclic carbamoyl pyridone derivative prodrug |
| 03/29/2012 | WO2012039197A1 Agent for enhancing trail sensitivity |
| 03/29/2012 | WO2012009678A8 Therapeutically active compositions and their method of use |
| 03/29/2012 | WO2011145909A3 Novel use of panduratin derivatives or an extract of boesenbergia pandurata for promoting muscle mass growth, fighting fatigue, and enhancing exercise performance capability |
| 03/29/2012 | WO2011109341A3 Oil composition containing carvone for use on aquatic creatures and amphibians |
| 03/29/2012 | US20120077985 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 03/29/2012 | US20120077838 Beta-2-Adrenoreceptor Agonists |
| 03/29/2012 | US20120077778 Ladder-Frame Polyether Conjugates |
| 03/29/2012 | US20120077754 Copolymer-1 improvements in compositions of copolymers |
| 03/29/2012 | US20120076874 Composition with improved bioavailability of saponin and method for improving the bioavailability of saponin (as amended) |
| 03/29/2012 | US20120076856 Orodispersible pharmaceutical composition of perindopril |
| 03/29/2012 | US20120076848 Method and system for effecting changes in pigmented tissue |
| 03/29/2012 | US20120076847 Medical instrument and method of manufacturing the same |
| 03/29/2012 | US20120076792 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 03/29/2012 | US20120076776 Method for treating inflamation by lymphocyte depletion or sequestering |
| 03/29/2012 | US20120076767 Process for concentration of a polypeptide |